Plandai Biotech Stock Technical Analysis
As of the 25th of February, Plandai Biotech holds the Variance of 17107.34, coefficient of variation of 980.96, and Risk Adjusted Performance of 0.0885. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Plandai Biotech, as well as the relationship between them. Please check Plandai Biotech market risk adjusted performance and total risk alpha to decide if Plandai Biotech is priced some-what accurately, providing market reflects its current price of 0.0 per share.
Plandai Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Plandai, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PlandaiPlandai |
Plandai Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Plandai Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Plandai Biotech.
| 11/27/2025 |
| 02/25/2026 |
If you would invest 0.00 in Plandai Biotech on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Plandai Biotech or generate 0.0% return on investment in Plandai Biotech over 90 days. Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmac... More
Plandai Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Plandai Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Plandai Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1011 | |||
| Maximum Drawdown | 1100.0 |
Plandai Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Plandai Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Plandai Biotech's standard deviation. In reality, there are many statistical measures that can use Plandai Biotech historical prices to predict the future Plandai Biotech's volatility.| Risk Adjusted Performance | 0.0885 | |||
| Jensen Alpha | 11.36 | |||
| Total Risk Alpha | (3.48) | |||
| Treynor Ratio | 0.6717 |
Plandai Biotech February 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0885 | |||
| Market Risk Adjusted Performance | 0.6817 | |||
| Mean Deviation | 32.89 | |||
| Coefficient Of Variation | 980.96 | |||
| Standard Deviation | 130.8 | |||
| Variance | 17107.34 | |||
| Information Ratio | 0.1011 | |||
| Jensen Alpha | 11.36 | |||
| Total Risk Alpha | (3.48) | |||
| Treynor Ratio | 0.6717 | |||
| Maximum Drawdown | 1100.0 | |||
| Skewness | 7.5 | |||
| Kurtosis | 57.63 |
Plandai Biotech Backtested Returns
Plandai Biotech is out of control given 3 months investment horizon. Plandai Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.1, which implies the firm had a 0.1 % return per unit of risk over the last 3 months. We were able to interpolate data for thirteen different technical indicators, which can help you to evaluate if expected returns of 13.33% are justified by taking the suggested risk. Use Plandai Biotech Variance of 17107.34, coefficient of variation of 980.96, and Risk Adjusted Performance of 0.0885 to evaluate company specific risk that cannot be diversified away. Plandai Biotech holds a performance score of 8 on a scale of zero to a hundred. The company holds a Beta of 19.83, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Plandai Biotech will likely underperform. Use Plandai Biotech market risk adjusted performance and total risk alpha , to analyze future returns on Plandai Biotech.
Auto-correlation | -0.12 |
Insignificant reverse predictability
Plandai Biotech has insignificant reverse predictability. Overlapping area represents the amount of predictability between Plandai Biotech time series from 27th of November 2025 to 11th of January 2026 and 11th of January 2026 to 25th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Plandai Biotech price movement. The serial correlation of -0.12 indicates that less than 12.0% of current Plandai Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | 0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Plandai Biotech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Plandai Biotech Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Plandai Biotech across different markets.
About Plandai Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Plandai Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Plandai Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Plandai Biotech price pattern first instead of the macroeconomic environment surrounding Plandai Biotech. By analyzing Plandai Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Plandai Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Plandai Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
Plandai Biotech February 25, 2026 Technical Indicators
Most technical analysis of Plandai help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Plandai from various momentum indicators to cycle indicators. When you analyze Plandai charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0885 | |||
| Market Risk Adjusted Performance | 0.6817 | |||
| Mean Deviation | 32.89 | |||
| Coefficient Of Variation | 980.96 | |||
| Standard Deviation | 130.8 | |||
| Variance | 17107.34 | |||
| Information Ratio | 0.1011 | |||
| Jensen Alpha | 11.36 | |||
| Total Risk Alpha | (3.48) | |||
| Treynor Ratio | 0.6717 | |||
| Maximum Drawdown | 1100.0 | |||
| Skewness | 7.5 | |||
| Kurtosis | 57.63 |
Other Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.